Assignee
IOLYX THERAPEUTICS INC
US·2 granted patents·7 pending applications·2 citations·filing 2022–2025
Top patents by PatentIndex Score
9 records- 0181US12263160B2Methods of treating ocular inflammatory diseasesIOLYX THERAPEUTICS INC·Filed 2022·Granted Apr 1, 2025·2 cites·21 claims
- 0268US2025009724A1Methods for ophthalmic delivery of roflumilastIOLYX THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0358US2023088371A1Ophthalmic pharmaceutical compositions of roflumilastIOLYX THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0458US2025032468A1Ocular surface topical administration of roflumilast for treatment of anterior and retinal-vitreous chamber ocular diseasesIOLYX THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0557US12102622B2Methods for ophthalmic delivery of roflumilastIOLYX THERAPEUTICS INC·Filed 2022·Granted Oct 1, 2024·0 cites·18 claims
- 0655US2025255809A1Ophthalmic pharmaceutical compositions of roflumilastIOLYX THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 0750US2025195489A1Methods of treating ocular inflammatory diseasesIOLYX THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 0849US2026083712A1Methods for treating patients with ocular comorbidities of an autoimmune disorderIOLYX THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 0947US2025339419A1Methods of treating ocular inflammatory diseasesIOLYX THERAPEUTICS INC·Filed 2025·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →